Genome-wide association study of preserved ratio impaired spirometry (PRISm)
Daniel H Higbee1,2, Alvin Lirio3, Fergus Hamilton1
1MRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.
This genome-wide association study identified novel genetic signals for preserved ratio impaired spirometry (PRISm). These genetic factors are linked to other lung diseases and type 2 diabetes, offering insights into PRISm pathogenesis.
Area of Science:
- Genetics
- Pulmonology
- Epidemiology
Background:
- Preserved ratio impaired spirometry (PRISm) is characterized by reduced FEV1 and a normal FEV1/FVC ratio.
- PRISm is linked to respiratory symptoms and various comorbidities.
- Understanding the genetic basis of PRISm is crucial for elucidating its pathogenesis.
Conclusions:
- This study presents the first GWAS to identify SNPs associated with PRISm.
- Four novel genetic signals (rs7652391, rs9431040, rs62018863, rs185937162) were discovered, highlighting the value of diverse lung function phenotypes in GWAS.
- Genetic factors underlying PRISm are significantly correlated with risks for other lung diseases and extrapulmonary comorbidities.
More Related Videos
00:07Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
